Persistent non-specific FDG uptake on PET imaging following hip arthroplasty

[1]  Abass Alavi,et al.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. , 2002, Seminars in nuclear medicine.

[2]  A. Alavi,et al.  Finding infection—help from PET , 2001, The Lancet.

[3]  W. Oyen,et al.  Radiopharmaceuticals to image infection and inflammation. , 2001, Seminars in nuclear medicine.

[4]  J. Talbot,et al.  [18F]-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: An unusual pitfall , 2001, Annals of nuclear medicine.

[5]  W. Oyen,et al.  New concepts in infection/inflammation imaging. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[6]  C. Van de Wiele,et al.  Fluorine-18 Fluorodeoxyglucose-Positron Emission Tomography: A Highly Accurate Imaging Modality for the Diagnosis of Chronic Musculoskeletal Infections , 2001 .

[7]  I. Heyligers,et al.  Detection of osteomyelitis using FDG and positron emission tomography. , 2001, The Journal of arthroplasty.

[8]  A. Alavi,et al.  The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  G Rosen,et al.  Attenuation-Correction Induced Artifact in F-18 FDG PET Imaging Following Total Knee Replacement. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[10]  M. Béhé,et al.  Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET , 2000, European Journal of Nuclear Medicine.

[11]  A. Alavi,et al.  Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography. , 2000, Clinical nuclear medicine.

[12]  G. V. von Schulthess,et al.  Infection imaging using whole-body FDG-PET , 2000, European Journal of Nuclear Medicine.

[13]  A. Alavi,et al.  Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. , 2000, Clinical nuclear medicine.

[14]  A. Ezzat,et al.  F-18 FDG uptake in breast infection and inflammation. , 2000, Clinical nuclear medicine.

[15]  R. Wahl,et al.  Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l-methionine, 67Ga-citrate, and 125I-HSA , 1999, European Journal of Nuclear Medicine.

[16]  A. Ezzat,et al.  F-18-FDG uptake in tuberculosis. , 1998, Clinical nuclear medicine.

[17]  H. Steinert,et al.  Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. , 1998, Blood.

[18]  R. Wahl,et al.  Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results , 1998, European Journal of Nuclear Medicine.

[19]  J S Karp,et al.  Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction. , 1998, European journal of nuclear medicine.

[20]  P. Shreve.  Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease , 1998, European Journal of Nuclear Medicine.

[21]  S. Yasuda,et al.  Diffuse F-18 FDG uptake in chronic thyroiditis. , 1997, Clinical nuclear medicine.

[22]  T Ido,et al.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  S. Goldsmith,et al.  Diagnosis of Musculoskeletal Infection Using Combined In‐111 Labeled Leukocyte and Tc‐99m SC Marrow Imaging , 1992, Clinical nuclear medicine.